SCS logo

Stem Cells Spin S.A. Stock Price

WSE:SCS Community·zł16.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

SCS Share Price Performance

zł0.39
0.11 (37.32%)
zł0.39
0.11 (37.32%)
Price zł0.39

SCS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with mediocre balance sheet.

5 Risks
0 Rewards

Stem Cells Spin S.A. Key Details

zł65.2k

Revenue

zł17.3k

Cost of Revenue

zł47.8k

Gross Profit

zł599.6k

Other Expenses

-zł551.7k

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 14, 2026
-0.013
73.41%
-846.47%
2.6%
View Full Analysis

About SCS

Founded
2009
Employees
1
CEO
Adam Symber
WebsiteView website
stemcellsspin.com.pl

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and application of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wroclaw, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O.

Recent SCS News & Updates

Recent updates

No updates